Will FDA approve any mRNA vaccine against prostate adenocarcinoma before 2028?
Health & MedicineOne-Off1jManifold MarketsGeen KYCGeverifieerde afwikkelingsgegevensRedelijk gekalibreerdHuidige gemeenschapsvoorspellingNee 79.4%
Voorspellers
3
Vraagtype
binary
Methodologie
Play-money forecasting platform
Brontype
Voorspelling
Marktdata
Bijgewerkt 23 minuten geleden
21 feb 23, 20:25 UTC31 dec 27, 22:59 UTC
Trends
Regels
Resolves YES if the FDA grants full approval for the commercial sale of any mRNA-based vaccine for the treatment of prostate adenocarcinoma in the United States before January 1, 2028.
- This does not include emergency use authorization or other forms of limited authorization.
- Resolves NO otherwise.
Open markten
Health & Medicine
POLYMARKETHantavirus pandemic in 2026?
- No-0.1pt97%
- Yes+0.1pt3%
- Totaal volume
- € 15,6 mln.
- 24u volume
- € 18,3K
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No96%
- Yes+1.9pt4%
- Totaal volume
- € 1,6 mln.
- 24u volume
- € 5,2K
KALSHIWhen will Intellia Therapeutics submit a BLA for Lonvo-z?
- before October+64.0pt98%
- before 2027+22.0pt98%
- before December+30.0pt98%
+3 extra uitkomsten
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+6.0pt65%
- September+2.0pt41%
- June28%
- Totaal volume
POLYMARKETNew pandemic in 2026?
- No+0.5pt94%
- Yes-0.5pt6%
- Totaal volume
- € 916K
- 24u volume
- € 1,5K
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 400097%
- Above 6000-2.0pt57%
+2 extra uitkomsten
- Totaal volume
- € 863,6K
- 24u volume
- € 1K
- Ebola pandemic in 2026?
- Will 3 mg THC beverages be federally legal to sell?
- Ebola pandemic in 2026?
- Measles cases in U.S. in 2026?
- FDA decision: Bepirovirsen by GlaxoSmithKline (in 2026)
- When will Heidi Overton be confirmed as Commissioner of the FDA?
- What will the average number of measles cases be during Trump's term?
- Will the FDA approve any psychedelic substance for medical use this year?
- When will the FDA reclassify BPC-157 to Category 1?
- FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
- Will the FDA approve CagriSema?
Veelgestelde vragen
- Wat zijn de huidige kansen voor Will FDA approve any mRNA vaccine against prostate adenocarcinoma before 2028??
- Manifold Markets prijst No op 79% per 8 september 2026.
- Wanneer wordt Will FDA approve any mRNA vaccine against prostate adenocarcinoma before 2028? afgewikkeld?
- Will FDA approve any mRNA vaccine against prostate adenocarcinoma before 2028? wordt naar verwachting op 31 december 2027 afgewikkeld.
- Hoe wordt Will FDA approve any mRNA vaccine against prostate adenocarcinoma before 2028? afgewikkeld?
- Manifold Markets wikkelt deze markt als volgt af: Resolves YES if the FDA grants full approval for the commercial sale of any mRNA-based vaccine for the treatment of prostate adenocarcinoma in the United States before January 1, 2028.